Nucleix

is an Israel-based liquid biopsy company that develops and supplies cancer screening and detection solutions for the healthcare industry...
Read more
Nucleix Chairman & CEO: Chris Hibberd

Chairman & CEO

Chris Hibberd

CEO Approval Rating

85/100

Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
25-100
Agree?
Funding
$91M

News

Mar 25, 2025
FinanzNachrichten
Nucleix: NHS Lothian and Nucleix Presented Data at EAU25 Showcasing Potential of Bladder EpiCheck to Improve Detection of Disease Recurrence in Non-Muscle Invasive Bladder Cancer (NMIBC) Patients
Sep 10, 2024
Pharmabiz
Nucleix: A. Menarini Diagnostics, Nucleix enter partnership for exclusive distribution of Bladder EpiCheck test in Europe
May 06, 2024
Business Wire
Press Release: Nucleix : Results from Pivotal Clinical Study Demonstrate Potential of Nucleix's Bladder EpiCheck to Improve Disease Recurrence Detection in Non-Muscle Invasive Bladder Cancer (NMIBC) Surveillance
Apr 04, 2024
Business Wire
Nucleix: Nucleix Demonstrates Potential of its PCR EpiCheck Assay to Accurately Differentiate Between Small Cell Lung Cancer (SCLC) Subtypes
Nov 06, 2023
Business Wire
Press Release: Nucleix : Nucleix Receives Reimbursement for Bladder EpiCheck in the Netherlands
Oct 23, 2023
FinanzNachrichten
Nucleix: Nucleix Bladder EpiCheck Now Available in France via the Association Francaise d'Urologie (AFU) Registry for Surveillance of Recurrence of Bladder Cancer
Oct 11, 2023
Yahoo
Nucleix: Nucleix Advances Early Lung Cancer Detection Program with Promising Performance Data and Appointment of Chief Scientific Officer
Oct 02, 2023
Business Wire
Press Release: Nucleix : Nucleix Announces Upcoming Presentation of Performance Data from Sightline Study of Lung EpiCheck at the American College of Chest Physicians (CHEST) 2023 Annual Meeting
May 05, 2023
Medical Product Outsourcing
Nucleix: Nucleix Earns FDA Nod for Non-Muscle Invasive Bladder Cancer Monitoring
Apr 13, 2023
Business Wire
Press Release: Nucleix : Nucleix to Premiere Data on its EpiCheck Lung Cancer Atlas at the 2023 American Association for Cancer Research Annual Meeting

Nucleix Competitors

1DELFI
2Guardant Health
3Resolution Bioscience
4Mursla
5Inivata
6Predicine
7Invitae
8Personalis
9Oncimmune
10Oncocyte

Trending Companies